Kuwana, M.
~ 300  Ergebnisse:
Personensuche X
?
 
?
4

IL‐15 is a biomarker involved in the development of rapidly..:

Shimizu, T. ; Koga, T. ; Furukawa, K....
Journal of Internal Medicine.  289 (2020)  2 - p. 206-220 , 2020
 
?
6

INFLAMMATORY MYOPATHIES:

Inoue, M. ; Uruha, A. ; Charuel, J....
Neuromuscular Disorders.  28 (2018)  - p. S75 , 2018
 
?
7

Antimelanoma differentiation‐associated protein 5 antibody ..:

Matsushita, T. ; Mizumaki, K. ; Kano, M....
British Journal of Dermatology.  176 (2017)  2 - p. 395-402 , 2017
 
?
8

Influences of timing of introduction of infliximab on the o..:

Hirohata, S. ; Kikuchi, H. ; Sawada, T....
Journal of the Neurological Sciences.  381 (2017)  - p. 76-77 , 2017
 
?
9

Recommendations for the management of neuro-Behcet's diseas..:

Kikuchi, H. ; Sawada, T. ; Okada, M....
Journal of the Neurological Sciences.  381 (2017)  - p. 646-647 , 2017
 
?
10

Long-term outcome of chronic progressive neurological manif..:

Hirohata, S. ; Kikuchi, H. ; Sawada, T....
Journal of the Neurological Sciences.  357 (2015)  - p. e200 , 2015
 
?
12

Dysregulated negative immune regulators in immune thrombocy..:

Kuwana, M.
ISBT Science Series.  9 (2014)  1 - p. 217-222 , 2014
 
?
14

Cardiac involvements in myasthenia gravis associated with a..:

Suzuki, S. ; Baba, A. ; Kaida, K....
European Journal of Neurology.  21 (2013)  2 - p. 223-230 , 2013
 
?
15

Predominant autoantibody response to GPIb/IX in a regulator..:

NISHIMOTO, T. ; SATOH, T. ; SIMPSON, E. K...
Journal of Thrombosis and Haemostasis.  11 (2013)  2 - p. 369-372 , 2013
 
1-15